FDA grants accelerated approval to nivolumab for patients with classical Hodgkin's lymphoma May 18, 2016
FDA approves Nuplazid for hallucinations and delusions associated with Parkinson's disease psychosis May 2, 2016
FDA grants accelerated approval to Venclexta for relapsed/refractory CLL with 17p deletion April 12, 2016
RSS